Schroder Investment Management Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-303,534
| Closed | -$783K | – | 1423 |
|
|
2017
Q2 | $783K | Sell |
303,534
-107,762
| -26% | -$278K | ﹤0.01% | 1010 |
|
|
2017
Q1 | $888K | Buy |
411,296
+279,863
| +213% | +$604K | ﹤0.01% | 969 |
|
|
2016
Q4 | $279K | Sell |
131,433
-15,848
| -11% | -$33.6K | ﹤0.01% | 1012 |
|
|
2016
Q3 | $493K | Sell |
147,281
-67,598
| -31% | -$226K | ﹤0.01% | 974 |
|
|
2016
Q2 | $675K | Sell |
214,879
-52,056
| -20% | -$164K | ﹤0.01% | 947 |
|
|
2016
Q1 | $846K | Buy |
+266,935
| New | +$846K | ﹤0.01% | 933 |
|
|
2015
Q1 | – | Sell |
-8,684,695
| Closed | -$67M | – | 1416 |
|
|
2014
Q4 | $67M | Sell |
8,684,695
-37,500
| -0.4% | -$289K | 0.13% | 196 |
|
|
2014
Q3 | $65.2M | Sell |
8,722,195
-6,945
| -0.1% | -$51.9K | 0.09% | 215 |
|
|
2014
Q2 | $84.5M | Sell |
8,729,140
-67,900
| -0.8% | -$657K | 0.11% | 177 |
|
|
2014
Q1 | $73.1M | Buy |
8,797,040
+3,675,872
| +72% | +$30.5M | 0.08% | 199 |
|
|
2013
Q4 | $43.2M | Buy |
5,121,168
+852,600
| +20% | +$7.2M | 0.05% | 286 |
|
|
2013
Q3 | $34M | Buy |
4,268,568
+805,200
| +23% | +$6.42M | 0.08% | 297 |
|
|
2013
Q2 | $26.7M | Buy |
+3,463,368
| New | +$26.7M | 0.07% | 330 |
|